Fractyl
NASDAQ: GUTSLexington, US · Delaware corporation · 6 known investors
Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms. The company serves patients and the physician community seeking alternatives to lifelong pharmaceutical treatments.
Founders & leadership
AW
ALLAN WILLDirector
SL
STANLEY LAPIDUSDirector
NS
NIMESH SHAHDirector
CG
CHRISTOPHER GABRIELIDirector
HR
HARITH RAJAGOPALANExecutive Officer, Director
JC
JAY CAPLANExecutive Officer, Director
LD
LISA DAVIDSONExecutive Officer
AR
AJAY ROYANDirector
Investors · 6
Reported raises · per SEC filings
Form D private placements▶$20.1MraisedJan 2022 · 4 investors · OtherRule 506(b)
▶$20.1MraisedJan 2022 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- ALLAN WILLDirector
- JUAN CARLOS LOPEZ-TALAVERAExecutive Officer
- CLIVE MEANWELLDirector
- LISA DAVIDSONExecutive Officer
- HARITH RAJAGOPALANExecutive Officer, Director
- WILLIAM BRADLEYDirector
- BRIAN DOVEYDirector
- KELLY BARNESDirector
- AMY SCHULMANDirector
- JAY CAPLANExecutive Officer
- MARC ELIADirector
- AJAY ROYANDirector
- Offering amount
- $20.1M
- Amount sold
- $20.1M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100MraisedJun 2021 · 15 investors · Other Health CareRule 506(b)
▶$100MraisedJun 2021 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- WILLIAM BRADLEYDirector
- JUAN CARLOS LOPEZ-TALAVERAExecutive Officer
- ALLAN WILLDirector
- CLIVE MEANWELLDirector
- MARGARET BORYSExecutive Officer
- JAY CAPLANExecutive Officer
- MICHAEL HUANGDirector
- LISA DAVIDSONExecutive Officer
- MARC ELIADirector
- HARITH RAJAGOPALANExecutive Officer, Director
- BRIAN DOVEYDirector
- AJAY ROYANDirector
- AMY SCHULMANDirector
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$44.8MraisedMar 2020 · 15 investors · Other Health CareRule 506(b)
▶$44.8MraisedMar 2020 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- WILLIAM BRADLEYDirector
- AMY SCHULMANDirector
- JUAN CARLOS LOPEZ-TALAVERAExecutive Officer
- HARITH RAJAGOPALANExecutive Officer, Director
- JAY CAPLANExecutive Officer
- MARGARET BORYSExecutive Officer
- LISA DAVIDSONExecutive Officer
- JOHN AMATRUDADirector
- CHRISTOPHER GABRIELIDirector
- STANLEY LAPIDUSDirector
- AJAY ROYANDirector
- BRIAN DOVEYDirector
- ALLAN WILLDirector
- Offering amount
- $44.8M
- Amount sold
- $44.8M
- Finders' fees
- $468K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$44MraisedDec 2017 · 19 investors · Other Health CareRule 506(b)
▶$44MraisedDec 2017 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- STANLEY LAPIDUSDirector
- HARITH RAJAGOPALANExecutive Officer, Director
- CHRISTOPHER GABRIELIDirector
- LISA DAVIDSONExecutive Officer
- AJAY ROYANDirector
- JOHN AMATRUDADirector
- ALLAN WILLDirector
- BRIAN DOVEYDirector
- JAY CAPLANExecutive Officer
- WILLIAM BRADLEYDirector
- Offering amount
- $44M
- Amount sold
- $44M
- Finders' fees
- $250K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$47.2MraisedFeb 2016 · 16 investors · Other Health CareRule 506(b)
▶$47.2MraisedFeb 2016 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- ALLAN WILLDirector
- STANLEY LAPIDUSDirector
- NIMESH SHAHDirector
- CHRISTOPHER GABRIELIDirector
- AJAY ROYANDirector
- HARITH RAJAGOPALANExecutive Officer, Director
- JAY CAPLANExecutive Officer, Director
- LISA DAVIDSONExecutive Officer
- Offering amount
- $47.2M
- Amount sold
- $47.2M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Morgan Stanley reiterates Fractyl Health stock rating on weight maintenance data By Investing.cominvesting.com · 2026
- Fractyl Health reports one-year data from weight maintenance trial By Investing.cominvesting.com · 2026
- H.C. Wainwright reiterates Buy on Fractyl Health stock at $8 By Investing.cominvesting.com · 2026
- Fractyl Health (GUTS) Is Up 14.0% After First GLP-1 Gene Therapy Trial Win And Profit Turnaroundfinance.yahoo.com · 2026
- Fractyl Health Q1 2026 results and going concern risk | GUTS Quarterly Report (10-Q)stocktitan.net · 2026
- Fractyl Health Secures $20M Funding to Advance Revolutionary Diabetes and Obesity Therapeuticsstocktitan.net · 2025